Nic G. Scalfarotto
Career history of Nic G. Scalfarotto
Former positions of Nic G. Scalfarotto
| Companies | Position | Start | End |
|---|---|---|---|
| KURA ONCOLOGY, INC. | General Counsel | - | - |
| X4 PHARMACEUTICALS, INC. | General Counsel | 2018-10-31 | - |
| AEGERION PHARMACEUTICALS, INC. | General Counsel | 2017-05-31 | - |
| MOMENTA PHARMACEUTICALS, INC. | General Counsel | 2011-05-15 | - |
Training of Nic G. Scalfarotto
| Alma Mater Studiorum - Università di Bologna | Doctorate Degree |
| Seton Hall University | Undergraduate Degree |
Statistics
International
| United States | 6 |
| Italy | 2 |
Operational
| General Counsel | 4 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| X4 PHARMACEUTICALS, INC. | Health Technology |
| KURA ONCOLOGY, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Nic G. Scalfarotto
- Experience
